Congenital pulmonary alveolar proteinosis
- Congenital PAP
- Primary ILD specific to childhood due to alveolar vascular disorder
- Primary interstitial lung disease specific to childhood due to alveolar vascular disorder
- Pulmonary alveolar proteinosis, congenital
On this page
The Rare Lung Diseases Consortium: Molecular Pathway-Driven Diagnostics and Therapeutics for Rare Lung Diseases is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research involving pulmonary alveolar proteinosis, Hermansky-Pudlak Syndrome, and Lymphangioleiomyomatosis. A pilot project program supports research into other rare lung diseases that complement the main research projects.